Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7 Prostatic Neoplasms 5 Brain Neoplasms 5 Carcinoma, Non-Small-Cell Lung 3 Radiation Injuries 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hemangioma 2 Breast Neoplasms 2 Urogenital Neoplasms 1 Scleroderma, Localized 1 Respiratory Distress Syndrome 1 Radiation Pneumonitis 1 Popliteal Cyst 1 Polycystic Ovary Syndrome 1 Pneumonia, Viral 1 Pneumonia 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Optic Neuritis 1 Neurodermatitis 1 Neoplastic Cells, Circulating 1 Neoplasms, Fibrous Tissue 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasms by Histologic Type 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1

Interventions

rozanolixizumab 11 efgartigimod alfa 10 zilucoplan 8 Prednisone 8 Cyclophosphamide 8 ravulizumab 7 Rituximab 7 Pyridostigmine Bromide 7 telitacicept 6 fludarabine 6 Tacrolimus 6 Mycophenolic Acid 6 eculizumab 5 Immunoglobulins, Intravenous 5 Hizentra 4 Azathioprine 4 Steroids 3 HBM9161 3 Data Collection 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Thymectomy 2 Prednisolone 2 Methylprednisolone 2 Methotrexate 2 Exercise 2 Diagnostic Self Evaluation 2 Blood Specimen Collection 2 tofacitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Adrenal Cortex Hormones × Clear all

NCT06342544 2026-01-21

IMCOMG

Fondation Ophtalmologique Adolphe de Rothschild

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡